KATLYN MONDAY: Open Payments
NPI 1508451717 · PALM DESERT, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,124 in 46 payments from 8 companies in 2025. Trend: 2023 $281 · 2024 $359 · 2025 $1,124
Food & beverage: $1,057Education: $67
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $266 |
| Amgen Inc. | 16 | $221 |
| Galderma Laboratories, L.P. | 9 | $197 |
| Regeneron Healthcare Solutions, Inc. | 3 | $182 |
| Incyte Corporation | 8 | $145 |
| Solta Medical, a division of Bausch Health US, LLC | 2 | $50 |
| Botanix SB Inc | 2 | $46 |
| Caris MPI, Inc. | 1 | $16 |
Products named: TREMFYA, OTEZLA, NEMLUVIO, DUPIXENT, OPZELURA, CLEAR+BRILLIANT, SOFDRA, MI CANCER SEEK.
Industry payments across CA — which companies pay providers there.
